Login / Signup

Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis.

Lian LiLiangliang XuSiqi ZhouPeng WangMing ZhangBo Li
Published in: BMC surgery (2022)
For HCC patients, the recurrence rate and long-term survival rate of left liver tumours were significantly higher than those of right liver tumours, indicating that the anatomical location of the tumour has a significant effect on the survival of HCC patients. Trial registration Chinese Clinical Trial Registry, ChiCTR2100052407. Registered 25 October 2021, http://www.chictr.org.cn/showproj.aspx?proj=135500 .
Keyphrases
  • end stage renal disease
  • clinical trial
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • study protocol
  • squamous cell carcinoma
  • open label